CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 18,838 shares (grant or award)
- 4 Grant or award Director acquired 10,015 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 425,000 shares at an average $20.55 ($8,733,955)
- 4 Open-market sale Director sold 27,280 shares at $21.12 ($576,154)
- 4 Open-market sale Director sold 11,686 shares at $20.96 ($244,939)
- 4 Open-market sale Director sold 11,437 shares at $21.00 ($240,177)
- 4 Shares withheld for taxes President and CEO gave up 73,943 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 22,605 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 31,044 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 25,941 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 30,310 shares (to pay taxes)
- 4 Planned sale Director sold 10,923 shares at $21.37 ($233,425)
Page 8 of 73 · 1,458 filings